BACKGROUND: Limited data exist concerning characteristics of community-acquired Staphylococcus aureus infections (CA-SAI) in central and eastern Kentucky. OBJECTIVE: To describe the incidence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections from January 1, 2004 through December 31, 2005, compare the number of CA-MRSA infections between years, and contrast treatment interventions and antibiotic susceptibility patterns of CA-SAI. METHODS: A concurrent and retrospective study was conducted in 125 patients less than 18 years of age with CA-SAI admitted to the hospital/clinic based on criteria from the Centers for Disease Control and Prevention. Data on demographics, length of stay,, antibiotic therapy, and antibiotic susceptibilities were collected. RESULTS: Seventy patients were included for analysis (CA-MRSA, n = 51; community-acquired methicillin-susceptible S. aureus [CA-MSSA], n = 19). No statistically significant differences were noted between the number of CA-MRSA infections and the total CA-SAI (9/15 in 2004 vs 42/55 in 2005; p = 0.15). Approximately 75% of patients with CA-SAI were admitted to the hospital with no significant difference in length of stay. Ninety percent of CA-SAI were skin and soft tissue infections. There-was a significant difference between groups with cutaneous abscesses (CA-MRSA, n 37 vs CA-MSSA, n = 6; p = 0.002). Greater than 95% of all isolates were susceptible to vancomycin and trimethoprim/sulfamethoxazole. Half of CA-MRSA patients received inappropriate antibiotic therapy with beta-lactain antibiotics or clindamycin without confirmatory disk diffusion test. Twenty-five (49%) patients with CA-MRSA received surgical debridement (S/D) and/or incision and drainage (I/D) with concomitant antibiotic therapy. Four patients with CA-MRSA were rehospitalized for subsequent infections; all 4 received appropriate antibiotic therapy. CONCLUSIONS: A noticeable increase in CA-MRSA infections with cutaneous abscess between 2004 and 2005 was noted. In patients receiving inappropriate antibiotic therapy, treatment success was attributed to concomitant S/D and I/D. Further analysis should focus on the impact of antibiotic therapy alone or in combination with S/D and I/D on the incidence of subsequent CA-MRSA infections.
机构:
Santa Casa Sch Med, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, SP, Brazil
Univ Sao Paulo, Div Pediat Infect Dis, Dept Pediat, Sao Paulo, SP, BrazilSanta Casa Sch Med, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, SP, Brazil
Badue Pereira, Maria Fernanda
Bando, Silvia Yumi
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, SP, BrazilSanta Casa Sch Med, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, SP, Brazil
Bando, Silvia Yumi
Sasagawa, Suzethe Matiko
论文数: 0引用数: 0
h-index: 0
机构:
Santa Casa Sch Med, Div Microbiol, Dept Pathol, Sao Paulo, SP, BrazilSanta Casa Sch Med, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, SP, Brazil
Sasagawa, Suzethe Matiko
da Silva, Cely Barreto
论文数: 0引用数: 0
h-index: 0
机构:
Santa Casa Sch Med, Div Microbiol, Dept Pathol, Sao Paulo, SP, Brazil
Santa Casa Sch Med, Infect Prevent & Control Team, Sao Paulo, SP, BrazilSanta Casa Sch Med, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, SP, Brazil
da Silva, Cely Barreto
Mimica, Marcelo Jenne
论文数: 0引用数: 0
h-index: 0
机构:
Santa Casa Sch Med, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, SP, Brazil
Santa Casa Sch Med, Div Microbiol, Dept Pathol, Sao Paulo, SP, BrazilSanta Casa Sch Med, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, SP, Brazil
Mimica, Marcelo Jenne
Berezin, Eitan Naaman
论文数: 0引用数: 0
h-index: 0
机构:
Santa Casa Sch Med, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, SP, BrazilSanta Casa Sch Med, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, SP, Brazil